Cytarabine Injection, Solution
Product Images NDC 25021-229

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 25021-229). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Cyt0b 0000 01)

Chemical structure diagram of cytarabine depicting its molecular components, including an amino group, a heterocyclic base with nitrogen atoms, and a sugar moiety with hydroxyl groups.*

FDA Label Image

Package Label – Principal Display Panel – Vial Label (Cyt0b 0000 02)

Label for Cytarabine Injection 100 mg per 5 mL (20 mg per mL) single-dose vial by Sagent Pharmaceuticals. The sterile, nonpyrogenic solution is for intravenous, intrathecal, and subcutaneous use. The label includes storage instructions, caution note for cytotoxic agent, lot number, and manufacturer information indicating it is made in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.